Clinical Trial Update: SA1211 Injection Phase 1 Study [Phase 1]

View source ↗

Summary

SA1211 Injection is a Phase 1 clinical trial sponsored by Suzhou Siran Biotechnology for chronic hepatitis B and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• SA1211

Snippet

Sponsor: Suzhou Siran Biotechnology Co.,Ltd. | Conditions: Chronic Hepatitis B | Phase 1 | Status: RECRUITING